The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Options

1 Oct 2012 07:00

RNS Number : 5255N
Sopheon PLC
01 October 2012
 



FOR IMMEDIATE RELEASE

1 October 2012

 

SOPHEON PLC

 

GRANT OF OPTIONS

 

Sopheon plc ("Sopheon" or " the Company") announces that it has granted options over ordinary shares of 5 pence each in the share capital of the Company ("Ordinary Shares") to certain directors. These grants are part of a wider grant of options over 5,285,598 Ordinary Shares, to both new and existing staff members.

 

Of this total, options over 285,000 Ordinary Shares have been granted to new members of staff. The remaining 5,000,598 have been granted to members of staff that have been with the company for ten years or longer. This second category represents the replacement of options previously granted to these members of staff approximately ten years ago, of which 146,112 lapsed in 2011 and 4,854,486 have lapsed in 2012 or are due to lapse in 2013. As part of this event, the options due to lapse in 2013 have been cancelled. Accordingly, the vast majority of this category can be considered as replacement or continuation of options in existence at December 31, 2011 and included in our financial statements as of that date.

 

Four directors are involved in this event. Barry Mence has been granted options over 122,500 ordinary shares, Andrew Michuda over 2,767,594, Arif Karimjee over 462,500 and Bernard Al over 25,000 ordinary shares. Following this grant, Barry Mence has options over a total of 485,000 ordinary shares, Andrew Michuda over 3,997,000, Arif Karimjee over 1,150,000 and Bernard Al over 25,000 ordinary shares.

 

All the options will vest evenly over 3 years, and are exercisable up to 10 years from the date of grant. The options have been granted at a price of 5.25 pence per share, being the mid-market closing price on AIM on 28 September 2012.

 

Chairman Barry Mence said:

 

"We are proud of the fact that we have so many staff that have been with us for ten years or longer, and have shown such commitment to our company and our vision. It is right that share option incentives which are due to lapse without exercise are renewed, with vesting conditions designed to encourage continued commitment to the company."

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Henrik Persson / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougall / Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Corning, Electrolux, Honeywell, Lockheed Martin, Philips and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAXNPAEEAEFF
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.